A convenient synthesis of 1-ethoxymethyl-5-nitro-6-substituted uracils

Tetrahedron Letters

Volumn 37, Issue 7, 1996, Pages 1031-1034

  Benhida, Rachid ^a   Aubertin, Anne Marie ^b   Grierson, David S ^c   Monneret, Claude ^a  

^a INSTITUT CURIE   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c INSTITUT DE CHIMIE DES SUBSTANCES NATURELLES   (France)

Author keywords

5 nitro 6 aryl uracils; HEPT analogs; HIV 1

Indexed keywords

ANTIVIRUS AGENT; RNA DIRECTED DNA POLYMERASE INHIBITOR; URACIL DERIVATIVE;

ARTICLE; CONTROLLED STUDY; CYTOPATHOGENIC EFFECT; DRUG SYNTHESIS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; REACTION ANALYSIS;

EID: 0030034305     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/0040-4039(95)02368-2     Document Type: Article

References (18)

1. (a) Barré-Sinoussi, F.; Cherman, J. C.; Rey, F.; Nugeyre, M. T.; Chamaret, S.; Gruest, J.; Dauguet, C; Axler-Blin, C.; Vézinet-Brun, F.; Rouzioux, C.; Rozenbaum, W.; Montagnier, L. Science 1983, 220, 868-871;
2. (b) Gallo, R. C.; Salahuddin, S. Z.; Popovic, M.; Shearer, G. M.; Kaplan, M.; Haynes, B. F.; Palker, T. J.; Redfield, R.; Oleske, J.; Safai, B.; White, G.; Foster, P.; Markham, P. D. Science 1984, 224, 500-503.
3. (a) Fischl, M. A.; et al. . N. Engl. J. Med. 1987, 317, 185-191;
4. (b) Lambert, J.S.; Seidlin, M.; Reichman, R. C.; Planck, C. S.; Laverty, M.; Morse, G. D.; Knupp, C.; McLaren, C.; Pettinelli, C.; Valentine, F. T.; Dolin, R. N. Engl. J. Med. 1990, 522, 1333-1345.
5. Richman, D. D.; Fischl, M. A.; Grieco, M. H.; Gattlieb, M. S.; Volberding, P. A.; Laskin, O.L.; Leedom, J. M.; Groopman, J. E.; Mildvan, D.; Hirsch, M. S.; Jackson, G. G.; Durack, D. T.; Nussinoff-Lehrman, S.; and the AZT collaborative Working Group. N. Engl. J. Med. 1987, 317, 192-197.
6. a) Verheyden, J. P. H. Current Opinion in Therapeutic Patents, 1991, 1, 1294-1304;
7. (b) De Clercq, E.; AIDS Res. Hum. Retroviruses 1992, 8, 119;
8. (c) Saunders, J.; Storer R. Drug News Perspect. 1992, 5, 153;
9. (d) Romero, D. L. Ann. Rep. in Med. Chem. 1994, 29, 123-132.
10. Goldman, M. E.; Nunberg, J. H.; O'Brien J. A.; Quintero, J. C.; Schleif, W. A.; Freund, K. F.; Gaul, S. L.; Saari, W. S.; Wai, J. S.; Huffman, J. M.; Anderson, P. S.; Hupe, D. J.; Emini, A. E.; Stern, A. M. Proc. Natl. Acad. Sci. USA 1991, 88, 6863-6867.
11. Miyasaka, T.; Tanaka, H.; Baba, M.; Hayakawa, H.; Walker, R.T.; Balzarini, J.; De Clercq, E. J. Med. Chem. 1989, 32, 2507-2509.
12. Baizarini, J., Karlsson, A.; De Clercq E., Molecular Pharmacol. 1993, 44, 694-701 and references cited therein.
13. MKC-442 demonstrating higher synergistic anti-HIV activity with AZT than nevirapine will soon enter clinical studies: Yuasa, S. et al., 9th Int. Conf. AIDS/4th STD World Congr.[June 6-11] Berlin, 1993. Abstract PO-B26-2064; Mitsubishi Kasei Corporation. Annual Report 1993.
14. Pontikis, R.; Monneret, C. Tetrahedron Lett., 1994, 35, 4351-4354.
15. Niedballa, U.; Vorbruggen, H. Angew. Chem., Int. Ed. Engl. 1970, 9, 461-462.
16. It must be noticed that in the case where the phenylthio group was introduced prior to the nitration-step, side-products having nitro substituent on the aromatic ring were obtained as main products.
17. +).
18. Dollé, V.; Nguyen, C. H.; Aubertin, A. M.; Kirn, A.; Andreola, M. L.; Jamieson, G.; Tarrago-Litvak, L.; Bisagni, E. J. Med. Chem. 1995, 38, 4679-4686.